Chuck Royce's LAB Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 2.89 M shares of Standard BioTools Inc. (LAB) worth $3.69 M, representing 0.04% of the portfolio. First purchased in 2013-Q2, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in LAB, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 840,951 shares. Largest reduction occurred in Q4 2019, reducing 122,400 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Standard BioTools (LAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Standard BioTools (LAB) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +3,300 | Add 0.00% | 3,300 | $17.58 |
| Q4 2013 | -3,300 | Sold Out | 0 | $0.00 |
| Q4 2018 | +148,400 | New Buy | 148,400 | $8.62 |
| Q1 2019 | +37,000 | Add 24.93% | 185,400 | $13.29 |
| Q3 2019 | -63,000 | Reduce 33.98% | 122,400 | $4.63 |
| Q4 2019 | -122,400 | Sold Out | 0 | $0.00 |
| Q2 2024 | +304,231 | New Buy | 304,231 | $1.77 |
| Q3 2024 | +310,321 | Add 102.00% | 614,552 | $1.93 |
| Q4 2024 | +840,951 | Add 136.84% | 1.46 M | $1.75 |
| Q1 2025 | +545,000 | Add 37.44% | 2 M | $1.08 |
| Q2 2025 | +636,618 | Add 31.82% | 2.64 M | $1.20 |
| Q3 2025 | +167,598 | Add 6.36% | 2.8 M | $1.30 |
| Q4 2025 | +80,810 | Add 2.88% | 2.89 M | $1.28 |
Chuck Royce's Standard BioTools Investment FAQs
Chuck Royce first purchased Standard BioTools Inc. (LAB) in Q2 2013, acquiring 3,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Standard BioTools Inc. (LAB) for 15 quarters since Q2 2013.
Chuck Royce's largest addition to Standard BioTools Inc. (LAB) was in Q4 2024, adding 1,455,503 shares worth $2.55 M.
According to the latest 13F filing for Q4 2025, Chuck Royce's firm, Royce & Associates Lp, owns 2,885,529 shares of Standard BioTools Inc. (LAB), valued at approximately $3.69 M.
As of the Q4 2025 filing, Standard BioTools Inc. (LAB) represents approximately 0.04% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Standard BioTools Inc. (LAB) was 2,885,529 shares, as reported at the end of Q4 2025.